eRegister's captcha

Supplementary Protection Certificate Details

Print page icon Print this page

Supplementary Protection Certificate (SPC) Summary
SPC No. 1999/002
Date of filing 26/02/1999
Notification of Application Published
Status Rejected
Notification of Grant Published
Date of Expiry of SPC
Applicant NOVARTIS AG
Schwarzwaldallee 215
4058 Basel
SWITZERLAND
Patent Number 71155
Title of Invention Acyl compounds
Date of Expiry of Patent 17/02/2011
Product Type Medicinal Product
Product Identity Valsartan or a pharmaceutically acceptable salt or ester thereof in combination with hydrochlorothiazide
Market AuthorisationIreland France 
Authorisation NoPA 13/91/1  344 300-5 
Authorisation Date10/12/1998 25/09/1997 
Identity of Product Authorised COTAREG 
Market Authorisation France 
Authorisation No 344 301-1 
Authorisation Date 25/09/1997 
Identity of Product Authorised COTAREG 
Market Authorisation France 
Authorisation No 344 302-1 
Authorisation Date 25/09/1997 
Identity of Product Authorised COTAREG 
Market Authorisation France 
Authorisation No 344 303-4 
Authorisation Date 25/09/1997 
Identity of Product Authorised COTAREG 
Address for Service FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39
IRELAND
Renewal Fees
10/03/2006 Request for grant of Supplementary Protection Certificate No. 1999/002 rejected in respect of Article 10(2) of Council Regulation (EEC) No. 1768/92. [Journal No. 2043, 05/04/2006]
20/12/2007 Appeal by Novartis against the rejection of Supplementary Protection Certificate application dismissed by the High Court.
24/03/2021 Written grounds of decision issued on 10 March 2005.